1 Study Coverage 1.1 Aurora Kinase B Product Introduction 1.2 Market by Type 1.2.1 Global Aurora Kinase B Market Size Growth Rate by Type 1.4.2 AZD-2811 1.4.3 CS-2164 1.2.4 Danusertib 1.2.5 Ilorasertib 1.2.6 NMI-900 1.2.7 Others 1.3 Market by Application 1.3.1 Global Aurora Kinase B Market Size Growth Rate by Application 1.3.2 Anaplastic Large Cell Lymphoma 1.3.3 Kidney Cancer 1.3.4 Lung Cancer 1.3.5 Prostate Cancer 1.3.6 Others 1.4 Study Objectives 1.5 Years Considered 2 Executive Summary 2.1 Global Aurora Kinase B Sales Estimates and Forecasts 2016-2027 2.2 Global Aurora Kinase B Revenue Estimates and Forecasts 2016-2027 2.3 Global Aurora Kinase B Revenue by Region: 2016 VS 2021 VS 2027 2.4 Global Top Aurora Kinase B Regions by Sales 2.4.1 Global Top Aurora Kinase B Regions by Sales (2016-2021) 2.4.2 Global Top Aurora Kinase B Regions by Sales (2022-2027) 2.5 Global Top Aurora Kinase B Regions by Revenue 2.5.1 Global Top Aurora Kinase B Regions by Revenue (2016-2021) 2.5.2 Global Top Aurora Kinase B Regions by Revenue (2022-2027) 2.6 North America 2.7 Europe 2.8 Asia-Pacific 2.9 Latin America 2.10 Middle East & Africa 3 Competition by Manufacturers 3.1 Global Aurora Kinase B Sales by Manufacturers 3.1.1 Global Top Aurora Kinase B Manufacturers by Sales (2016-2021) 3.1.2 Global Top Aurora Kinase B Manufacturers Market Share by Sales (2016-2021) 3.1.3 Global Top 10 and Top 5 Companies by Aurora Kinase B Sales in 2020 3.2 Global Aurora Kinase B Revenue by Manufacturers 3.2.1 Global Top Aurora Kinase B Manufacturers by Revenue (2016-2021) 3.2.2 Global Top Aurora Kinase B Manufacturers Market Share by Revenue (2016-2021) 3.2.3 Global Top 10 and Top 5 Companies by Aurora Kinase B Revenue in 2020 3.3 Global Aurora Kinase B Sales Price by Manufacturers 3.4 Analysis of Competitive Landscape 3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Aurora Kinase B Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.4.3 Global Aurora Kinase B Manufacturers Geographical Distribution 3.5 Mergers & Acquisitions, Expansion Plans 4 Market Size by Type 4.1 Global Aurora Kinase B Sales by Type 4.1.1 Global Aurora Kinase B Historical Sales by Type (2016-2021) 4.1.2 Global Aurora Kinase B Forecasted Sales by Type (2022-2027) 4.1.3 Global Aurora Kinase B Sales Market Share by Type (2016-2027) 4.2 Global Aurora Kinase B Revenue by Type 4.2.1 Global Aurora Kinase B Historical Revenue by Type (2016-2021) 4.2.2 Global Aurora Kinase B Forecasted Revenue by Type (2022-2027) 4.2.3 Global Aurora Kinase B Revenue Market Share by Type (2016-2027) 4.3 Global Aurora Kinase B Price by Type 4.3.1 Global Aurora Kinase B Price by Type (2016-2021) 4.3.2 Global Aurora Kinase B Price Forecast by Type (2022-2027) 5 Market Size by Application 5.1 Global Aurora Kinase B Sales by Application 5.1.1 Global Aurora Kinase B Historical Sales by Application (2016-2021) 5.1.2 Global Aurora Kinase B Forecasted Sales by Application (2022-2027) 5.1.3 Global Aurora Kinase B Sales Market Share by Application (2016-2027) 5.2 Global Aurora Kinase B Revenue by Application 5.2.1 Global Aurora Kinase B Historical Revenue by Application (2016-2021) 5.2.2 Global Aurora Kinase B Forecasted Revenue by Application (2022-2027) 5.2.3 Global Aurora Kinase B Revenue Market Share by Application (2016-2027) 5.3 Global Aurora Kinase B Price by Application 5.3.1 Global Aurora Kinase B Price by Application (2016-2021) 5.3.2 Global Aurora Kinase B Price Forecast by Application (2022-2027) 6 North America 6.1 North America Aurora Kinase B Market Size by Type 6.1.1 North America Aurora Kinase B Sales by Type (2016-2027) 6.1.2 North America Aurora Kinase B Revenue by Type (2016-2027) 6.2 North America Aurora Kinase B Market Size by Application 6.2.1 North America Aurora Kinase B Sales by Application (2016-2027) 6.2.2 North America Aurora Kinase B Revenue by Application (2016-2027) 6.3 North America Aurora Kinase B Market Size by Country 6.3.1 North America Aurora Kinase B Sales by Country (2016-2027) 6.3.2 North America Aurora Kinase B Revenue by Country (2016-2027) 6.3.3 U.S. 6.3.4 Canada 7 Europe 7.1 Europe Aurora Kinase B Market Size by Type 7.1.1 Europe Aurora Kinase B Sales by Type (2017-2027) 7.1.2 Europe Aurora Kinase B Revenue by Type (2017-2027) 7.2 Europe Aurora Kinase B Market Size by Application 7.2.1 Europe Aurora Kinase B Sales by Application (2017-2027) 7.2.2 Europe Aurora Kinase B Revenue by Application (2017-2027) 7.3 Europe Aurora Kinase B Market Size by Country 7.3.1 Europe Aurora Kinase B Sales by Country (2017-2027) 7.3.2 Europe Aurora Kinase B Revenue by Country (2017-2027) 7.3.3 Germany 7.3.4 France 7.3.5 U.K. 7.3.6 Italy 7.3.7 Russia 8 Asia Pacific 8.1 Asia Pacific Aurora Kinase B Market Size by Type 8.1.1 Asia Pacific Aurora Kinase B Sales by Type (2018-2027) 8.1.2 Asia Pacific Aurora Kinase B Revenue by Type (2018-2027) 8.2 Asia Pacific Aurora Kinase B Market Size by Application 8.2.1 Asia Pacific Aurora Kinase B Sales by Application (2018-2027) 8.2.2 Asia Pacific Aurora Kinase B Revenue by Application (2018-2027) 8.3 Asia Pacific Aurora Kinase B Market Size by Region 8.3.1 Asia Pacific Aurora Kinase B Sales by Region (2018-2027) 8.3.2 Asia Pacific Aurora Kinase B Revenue by Region (2018-2027) 8.3.3 China 8.3.4 Japan 8.3.5 South Korea 8.3.6 India 8.3.7 Australia 8.3.8 Taiwan 8.3.9 Indonesia 8.3.10 Thailand 8.3.11 Malaysia 8.3.12 Philippines 9 Latin America 9.1 Latin America Aurora Kinase B Market Size by Type 9.1.1 Latin America Aurora Kinase B Sales by Type (2019-2027) 9.1.2 Latin America Aurora Kinase B Revenue by Type (2019-2027) 9.2 Latin America Aurora Kinase B Market Size by Application 9.2.1 Latin America Aurora Kinase B Sales by Application (2019-2027) 9.2.2 Latin America Aurora Kinase B Revenue by Application (2019-2027) 9.3 Latin America Aurora Kinase B Market Size by Country 9.3.1 Latin America Aurora Kinase B Sales by Country (2019-2027) 9.3.2 Latin America Aurora Kinase B Revenue by Country (2019-2027) 9.3.3 Mexico 9.3.4 Brazil 9.3.5 Argentina 6 Middle East and Africa 6.1 Middle East and Africa Aurora Kinase B Market Size by Type 6.1.1 Middle East and Africa Aurora Kinase B Sales by Type (2016-2027) 6.1.2 Middle East and Africa Aurora Kinase B Revenue by Type (2016-2027) 6.2 Middle East and Africa Aurora Kinase B Market Size by Application 6.2.1 Middle East and Africa Aurora Kinase B Sales by Application (2016-2027) 6.2.2 Middle East and Africa Aurora Kinase B Revenue by Application (2016-2027) 6.3 Middle East and Africa Aurora Kinase B Market Size by Country 6.3.1 Middle East and Africa Aurora Kinase B Sales by Country (2016-2027) 6.3.2 Middle East and Africa Aurora Kinase B Revenue by Country (2016-2027) 6.3.3 Turkey 6.3.4 Saudi Arabia 6.3.5 U.A.E 11 Company Profiles 11.1 AbbVie Inc 11.1.1 AbbVie Inc Corporation Information 11.1.2 AbbVie Inc Overview 11.1.3 AbbVie Inc Aurora Kinase B Sales, Price, Revenue and Gross Margin (2016-2021) 11.1.4 AbbVie Inc Aurora Kinase B Product Description 11.1.5 AbbVie Inc Related Developments 11.2 Advenchen Laboratories LLC 11.2.1 Advenchen Laboratories LLC Corporation Information 11.2.2 Advenchen Laboratories LLC Overview 11.2.3 Advenchen Laboratories LLC Aurora Kinase B Sales, Price, Revenue and Gross Margin (2016-2021) 11.2.4 Advenchen Laboratories LLC Aurora Kinase B Product Description 11.2.5 Advenchen Laboratories LLC Related Developments 11.3 Aeterna Zentaris Inc 11.3.1 Aeterna Zentaris Inc Corporation Information 11.3.2 Aeterna Zentaris Inc Overview 11.3.3 Aeterna Zentaris Inc Aurora Kinase B Sales, Price, Revenue and Gross Margin (2016-2021) 11.3.4 Aeterna Zentaris Inc Aurora Kinase B Product Description 11.3.5 Aeterna Zentaris Inc Related Developments 11.4 Amgen Inc 11.4.1 Amgen Inc Corporation Information 11.4.2 Amgen Inc Overview 11.4.3 Amgen Inc Aurora Kinase B Sales, Price, Revenue and Gross Margin (2016-2021) 11.4.4 Amgen Inc Aurora Kinase B Product Description 11.4.5 Amgen Inc Related Developments 11.5 AstraZeneca Plc 11.5.1 AstraZeneca Plc Corporation Information 11.5.2 AstraZeneca Plc Overview 11.5.3 AstraZeneca Plc Aurora Kinase B Sales, Price, Revenue and Gross Margin (2016-2021) 11.5.4 AstraZeneca Plc Aurora Kinase B Product Description 11.5.5 AstraZeneca Plc Related Developments 11.6 Chipscreen Biosciences Ltd 11.6.1 Chipscreen Biosciences Ltd Corporation Information 11.6.2 Chipscreen Biosciences Ltd Overview 11.6.3 Chipscreen Biosciences Ltd Aurora Kinase B Sales, Price, Revenue and Gross Margin (2016-2021) 11.6.4 Chipscreen Biosciences Ltd Aurora Kinase B Product Description 11.6.5 Chipscreen Biosciences Ltd Related Developments 11.7 Cielo Therapeutics Inc 11.7.1 Cielo Therapeutics Inc Corporation Information 11.7.2 Cielo Therapeutics Inc Overview 11.7.3 Cielo Therapeutics Inc Aurora Kinase B Sales, Price, Revenue and Gross Margin (2016-2021) 11.7.4 Cielo Therapeutics Inc Aurora Kinase B Product Description 11.7.5 Cielo Therapeutics Inc Related Developments 11.8 Sanofi 11.8.1 Sanofi Corporation Information 11.8.2 Sanofi Overview 11.8.3 Sanofi Aurora Kinase B Sales, Price, Revenue and Gross Margin (2016-2021) 11.8.4 Sanofi Aurora Kinase B Product Description 11.8.5 Sanofi Related Developments 11.9 Sareum Holdings Plc 11.9.1 Sareum Holdings Plc Corporation Information 11.9.2 Sareum Holdings Plc Overview 11.9.3 Sareum Holdings Plc Aurora Kinase B Sales, Price, Revenue and Gross Margin (2016-2021) 11.9.4 Sareum Holdings Plc Aurora Kinase B Product Description 11.9.5 Sareum Holdings Plc Related Developments 11.1 AbbVie Inc 11.1.1 AbbVie Inc Corporation Information 11.1.2 AbbVie Inc Overview 11.1.3 AbbVie Inc Aurora Kinase B Sales, Price, Revenue and Gross Margin (2016-2021) 11.1.4 AbbVie Inc Aurora Kinase B Product Description 11.1.5 AbbVie Inc Related Developments 12 Value Chain and Sales Channels Analysis 12.1 Aurora Kinase B Value Chain Analysis 12.2 Aurora Kinase B Key Raw Materials 12.2.1 Key Raw Materials 12.2.2 Raw Materials Key Suppliers 12.3 Aurora Kinase B Production Mode & Process 12.4 Aurora Kinase B Sales and Marketing 12.4.1 Aurora Kinase B Sales Channels 12.4.2 Aurora Kinase B Distributors 12.5 Aurora Kinase B Customers 13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis 13.1 Aurora Kinase B Industry Trends 13.2 Aurora Kinase B Market Drivers 13.3 Aurora Kinase B Market Challenges 13.4 Aurora Kinase B Market Restraints 14 Key Findings in The Global Aurora Kinase B Study 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.2 Data Source 15.2 Author Details 15.3 Disclaimer

List of Tables Table 1. Global Aurora Kinase B Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million) Table 2. Major Manufacturers of AZD-2811 Table 3. Major Manufacturers of CS-2164 Table 4. Major Manufacturers of Danusertib Table 5. Major Manufacturers of Ilorasertib Table 6. Major Manufacturers of NMI-900 Table 7. Major Manufacturers of Others Table 8. Global Aurora Kinase B Market Size Growth Rate by Application, 2016 VS 2021 VS 2027 (US$ Million) Table 9. Global Aurora Kinase B Revenue by Region: 2016 VS 2021 VS 2027 (US$ Million) Table 10. Global Aurora Kinase B Sales by Region (2016-2021) & (K Pcs) Table 11. Global Aurora Kinase B Sales Market Share by Region (2016-2021) Table 12. Global Aurora Kinase B Sales by Region (2016-2021) & (K Pcs) Table 13. Global Aurora Kinase B Sales Market Share by Region (2022-2027) Table 14. Global Aurora Kinase B Revenue by Region (2016-2021) & (US$ Million) Table 15. Global Aurora Kinase B Revenue Market Share by Region (2016-2021) Table 16. Global Aurora Kinase B Revenue by Region (2022-2027) & (US$ Million) Table 17. Global Aurora Kinase B Revenue Market Share by Region (2022-2027) Table 18. Global Aurora Kinase B Sales by Manufacturers (2016-2021) & (K Pcs) Table 19. Global Aurora Kinase B Sales Share by Manufacturers (2016-2021) Table 20. Global Aurora Kinase B Revenue by Manufacturers (2016-2021) & (US$ Million) Table 21. Global Aurora Kinase B Revenue Share by Manufacturers (2016-2021) Table 22. Aurora Kinase B Price by Manufacturers 2016-2021 (USD/Pcs) Table 23. Global Aurora Kinase B Manufacturers Market Concentration Ratio (CR5 and HHI) Table 24. Global Aurora Kinase B by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Aurora Kinase B as of 2020) Table 25. Aurora Kinase B Manufacturing Base Distribution and Headquarters Table 26. Manufacturers Aurora Kinase B Product Offered Table 27. Date of Manufacturers Enter into Aurora Kinase B Market Table 28. Mergers & Acquisitions, Expansion Plans Table 29. Global Aurora Kinase B Sales by Type (2016-2021) & (K Pcs) Table 30. Global Aurora Kinase B Sales by Type (2022-2027) & (K Pcs) Table 31. Global Aurora Kinase B Sales Share by Type (2016-2021) Table 32. Global Aurora Kinase B Sales Share by Type (2022-2027) Table 33. Global Aurora Kinase B Revenue by Type (2016-2021) & (US$ Million) Table 34. Global Aurora Kinase B Revenue by Type (2022-2027) & (US$ Million) Table 35. Global Aurora Kinase B Revenue Share by Type (2016-2021) Table 36. Global Aurora Kinase B Revenue Share by Type (2022-2027) Table 37. Aurora Kinase B Price by Type (2016-2021) & (USD/Pcs) Table 38. Global Aurora Kinase B Price Forecast by Type (2022-2027) & (USD/Pcs) Table 39. Global Aurora Kinase B Sales by Application (2016-2021) & (K Pcs) Table 40. Global Aurora Kinase B Sales by Application (2022-2027) & (K Pcs) Table 41. Global Aurora Kinase B Sales Share by Application (2016-2021) Table 42. Global Aurora Kinase B Sales Share by Application (2022-2027) Table 43. Global Aurora Kinase B Revenue by Application (2016-2021) & (US$ Million) Table 44. Global Aurora Kinase B Revenue by Application (2022-2027) & (US$ Million) Table 45. Global Aurora Kinase B Revenue Share by Application (2016-2021) Table 46. Global Aurora Kinase B Revenue Share by Application (2022-2027) Table 47. Aurora Kinase B Price by Application (2016-2021) & (USD/Pcs) Table 48. Global Aurora Kinase B Price Forecast by Application (2022-2027) & (USD/Pcs) Table 49. North America Aurora Kinase B Sales by Type (2016-2021) & (K Pcs) Table 50. North America Aurora Kinase B Sales by Type (2022-2027) & (K Pcs) Table 51. North America Aurora Kinase B Revenue by Type (2016-2021) & (US$ Million) Table 52. North America Aurora Kinase B Revenue by Type (2022-2027) & (US$ Million) Table 53. North America Aurora Kinase B Sales by Application (2016-2021) & (K Pcs) Table 54. North America Aurora Kinase B Sales by Application (2022-2027) & (K Pcs) Table 55. North America Aurora Kinase B Revenue by Application (2016-2021) & (US$ Million) Table 56. North America Aurora Kinase B Revenue by Application (2022-2027) & (US$ Million) Table 57. North America Aurora Kinase B Sales by Country (2016-2021) & (K Pcs) Table 58. North America Aurora Kinase B Sales by Country (2022-2027) & (K Pcs) Table 59. North America Aurora Kinase B Revenue by Country (2016-2021) & (US$ Million) Table 60. North America Aurora Kinase B Revenue by Country (2022-2027) & (US$ Million) Table 61. Europe Aurora Kinase B Sales by Type (2016-2021) & (K Pcs) Table 62. Europe Aurora Kinase B Sales by Type (2022-2027) & (K Pcs) Table 63. Europe Aurora Kinase B Revenue by Type (2016-2021) & (US$ Million) Table 64. Europe Aurora Kinase B Revenue by Type (2022-2027) & (US$ Million) Table 65. Europe Aurora Kinase B Sales by Application (2016-2021) & (K Pcs) Table 66. Europe Aurora Kinase B Sales by Application (2022-2027) & (K Pcs) Table 67. Europe Aurora Kinase B Revenue by Application (2016-2021) & (US$ Million) Table 68. Europe Aurora Kinase B Revenue by Application (2022-2027) & (US$ Million) Table 69. Europe Aurora Kinase B Sales by Country (2016-2021) & (K Pcs) Table 70. Europe Aurora Kinase B Sales by Country (2022-2027) & (K Pcs) Table 71. Europe Aurora Kinase B Revenue by Country (2016-2021) & (US$ Million) Table 72. Europe Aurora Kinase B Revenue by Country (2022-2027) & (US$ Million) Table 73. Asia Pacific Aurora Kinase B Sales by Type (2016-2021) & (K Pcs) Table 74. Asia Pacific Aurora Kinase B Sales by Type (2022-2027) & (K Pcs) Table 75. Asia Pacific Aurora Kinase B Revenue by Type (2016-2021) & (US$ Million) Table 76. Asia Pacific Aurora Kinase B Revenue by Type (2022-2027) & (US$ Million) Table 77. Asia Pacific Aurora Kinase B Sales by Application (2016-2021) & (K Pcs) Table 78. Asia Pacific Aurora Kinase B Sales by Application (2022-2027) & (K Pcs) Table 79. Asia Pacific Aurora Kinase B Revenue by Application (2016-2021) & (US$ Million) Table 80. Asia Pacific Aurora Kinase B Revenue by Application (2022-2027) & (US$ Million) Table 81. Asia Pacific Aurora Kinase B Sales by Region (2016-2021) & (K Pcs) Table 82. Asia Pacific Aurora Kinase B Sales by Region (2022-2027) & (K Pcs) Table 83. Asia Pacific Aurora Kinase B Revenue by Region (2016-2021) & (US$ Million) Table 84. Asia Pacific Aurora Kinase B Revenue by Region (2022-2027) & (US$ Million) Table 85. Latin America Aurora Kinase B Sales by Type (2016-2021) & (K Pcs) Table 86. Latin America Aurora Kinase B Sales by Type (2022-2027) & (K Pcs) Table 87. Latin America Aurora Kinase B Revenue by Type (2016-2021) & (US$ Million) Table 88. Latin America Aurora Kinase B Revenue by Type (2022-2027) & (US$ Million) Table 89. Latin America Aurora Kinase B Sales by Application (2016-2021) & (K Pcs) Table 90. Latin America Aurora Kinase B Sales by Application (2022-2027) & (K Pcs) Table 91. Latin America Aurora Kinase B Revenue by Application (2016-2021) & (US$ Million) Table 92. Latin America Aurora Kinase B Revenue by Application (2022-2027) & (US$ Million) Table 93. Latin America Aurora Kinase B Sales by Country (2016-2021) & (K Pcs) Table 94. Latin America Aurora Kinase B Sales by Country (2022-2027) & (K Pcs) Table 95. Latin America Aurora Kinase B Revenue by Country (2016-2021) & (US$ Million) Table 96. Latin America Aurora Kinase B Revenue by Country (2022-2027) & (US$ Million) Table 97. Middle East and Africa Aurora Kinase B Sales by Type (2016-2021) & (K Pcs) Table 98. Middle East and Africa Aurora Kinase B Sales by Type (2022-2027) & (K Pcs) Table 99. Middle East and Africa Aurora Kinase B Revenue by Type (2016-2021) & (US$ Million) Table 100. Middle East and Africa Aurora Kinase B Revenue by Type (2022-2027) & (US$ Million) Table 101. Middle East and Africa Aurora Kinase B Sales by Application (2016-2021) & (K Pcs) Table 102. Middle East and Africa Aurora Kinase B Sales by Application (2022-2027) & (K Pcs) Table 103. Middle East and Africa Aurora Kinase B Revenue by Application (2016-2021) & (US$ Million) Table 104. Middle East and Africa Aurora Kinase B Revenue by Application (2022-2027) & (US$ Million) Table 105. Middle East and Africa Aurora Kinase B Sales by Country (2016-2021) & (K Pcs) Table 106. Middle East and Africa Aurora Kinase B Sales by Country (2022-2027) & (K Pcs) Table 107. Middle East and Africa Aurora Kinase B Revenue by Country (2016-2021) & (US$ Million) Table 108. Middle East and Africa Aurora Kinase B Revenue by Country (2022-2027) & (US$ Million) Table 109. AbbVie Inc Corporation Information Table 110. AbbVie Inc Description and Major Businesses Table 111. AbbVie Inc Aurora Kinase B Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021) Table 112. AbbVie Inc Aurora Kinase B Product Table 113. AbbVie Inc Recent Developments Table 114. Advenchen Laboratories LLC Corporation Information Table 115. Advenchen Laboratories LLC Description and Major Businesses Table 116. Advenchen Laboratories LLC Aurora Kinase B Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021) Table 117. Advenchen Laboratories LLC Aurora Kinase B Product Table 118. Advenchen Laboratories LLC Recent Developments Table 119. Aeterna Zentaris Inc Corporation Information Table 120. Aeterna Zentaris Inc Description and Major Businesses Table 121. Aeterna Zentaris Inc Aurora Kinase B Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021) Table 122. Aeterna Zentaris Inc Aurora Kinase B Product Table 123. Aeterna Zentaris Inc Recent Developments Table 124. Amgen Inc Corporation Information Table 125. Amgen Inc Description and Major Businesses Table 126. Amgen Inc Aurora Kinase B Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021) Table 127. Amgen Inc Aurora Kinase B Product Table 128. Amgen Inc Recent Developments Table 129. AstraZeneca Plc Corporation Information Table 130. AstraZeneca Plc Description and Major Businesses Table 131. AstraZeneca Plc Aurora Kinase B Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021) Table 132. AstraZeneca Plc Aurora Kinase B Product Table 133. AstraZeneca Plc Recent Developments Table 134. Chipscreen Biosciences Ltd Corporation Information Table 135. Chipscreen Biosciences Ltd Description and Major Businesses Table 136. Chipscreen Biosciences Ltd Aurora Kinase B Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021) Table 137. Chipscreen Biosciences Ltd Aurora Kinase B Product Table 138. Chipscreen Biosciences Ltd Recent Developments Table 139. Cielo Therapeutics Inc Corporation Information Table 140. Cielo Therapeutics Inc Description and Major Businesses Table 141. Cielo Therapeutics Inc Aurora Kinase B Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021) Table 142. Cielo Therapeutics Inc Aurora Kinase B Product Table 143. Cielo Therapeutics Inc Recent Developments Table 144. Sanofi Corporation Information Table 145. Sanofi Description and Major Businesses Table 146. Sanofi Aurora Kinase B Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021) Table 147. Sanofi Aurora Kinase B Product Table 148. Sanofi Recent Developments Table 149. Sareum Holdings Plc Corporation Information Table 150. Sareum Holdings Plc Description and Major Businesses Table 151. Sareum Holdings Plc Aurora Kinase B Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021) Table 152. Sareum Holdings Plc Aurora Kinase B Product Table 153. Sareum Holdings Plc Recent Developments Table 154. Key Raw Materials Lists Table 155. Raw Materials Key Suppliers Lists Table 156. Aurora Kinase B Distributors List Table 157. Aurora Kinase B Customers List Table 158. Aurora Kinase B Market Trends Table 159. Aurora Kinase B Market Drivers Table 160. Aurora Kinase B Market Challenges Table 161. Aurora Kinase B Market Restraints Table 162. Research Programs/Design for This Report Table 163. Key Data Information from Secondary Sources Table 164. Key Data Information from Primary Sources List of Figures Figure 1. Aurora Kinase B Product Picture Figure 2. Global Aurora Kinase B Market Share by Type in 2020 & 2027 Figure 3. AZD-2811 Product Picture Figure 4. CS-2164 Product Picture Figure 5. Danusertib Product Picture Figure 6. Ilorasertib Product Picture Figure 7. NMI-900 Product Picture Figure 8. Others Product Picture Figure 9. Global Aurora Kinase B Sales Market Share by Application in 2020 & 2027 Figure 10. Anaplastic Large Cell Lymphoma Figure 11. Kidney Cancer Figure 12. Lung Cancer Figure 13. Prostate Cancer Figure 14. Others Figure 15. Aurora Kinase B Report Years Considered Figure 16. Global Aurora Kinase B Sales 2016-2027 (K Pcs) Figure 17. Global Aurora Kinase B Revenue, (US$ Million), 2016 VS 2021 VS 2027 Figure 18. Global Aurora Kinase B Revenue 2016-2027 (US$ Million) Figure 19. Global Aurora Kinase B Revenue Market Share by Region in Percentage: 2020 Versus 2027 Figure 20. Global Aurora Kinase B Sales Market Share by Region (2016-2021) Figure 21. Global Aurora Kinase B Sales Market Share by Region (2022-2027) Figure 22. North America Aurora Kinase B Sales YoY (2016-2027) & (K Pcs) Figure 23. North America Aurora Kinase B Revenue YoY (2016-2027) & (US$ Million) Figure 24. Europe Aurora Kinase B Sales YoY (2016-2027) & (K Pcs) Figure 25. Europe Aurora Kinase B Revenue YoY (2016-2027) & (US$ Million) Figure 26. Asia-Pacific Aurora Kinase B Sales YoY (2016-2027) & (K Pcs) Figure 27. Asia-Pacific Aurora Kinase B Revenue YoY (2016-2027) & (US$ Million) Figure 28. Latin America Aurora Kinase B Sales YoY (2016-2027) & (K Pcs) Figure 29. Latin America Aurora Kinase B Revenue YoY (2016-2027) & (US$ Million) Figure 30. Middle East & Africa Aurora Kinase B Sales YoY (2016-2027) & (K Pcs) Figure 31. Middle East & Africa Aurora Kinase B Revenue YoY (2016-2027) & (US$ Million) Figure 32. The Top 10 and Top 5 Players Market Share by Aurora Kinase B Sales in 2020 Figure 33. The Top 10 and Top 5 Players Market Share by Aurora Kinase B Revenue in 2020 Figure 34. Aurora Kinase B Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2016 VS 2020 Figure 35. Global Aurora Kinase B Sales Market Share by Type (2016-2027) Figure 36. Global Aurora Kinase B Revenue Market Share by Type (2016-2027) Figure 37. Global Aurora Kinase B Sales Market Share by Application (2016-2027) Figure 38. Global Aurora Kinase B Revenue Market Share by Application (2016-2027) Figure 39. North America Aurora Kinase B Sales Market Share by Type (2016-2027) Figure 40. North America Aurora Kinase B Revenue Market Share by Type (2016-2027) Figure 41. North America Aurora Kinase B Sales Market Share by Application (2016-2027) Figure 42. North America Aurora Kinase B Revenue Market Share by Application (2016-2027) Figure 43. North America Aurora Kinase B Sales Share by Country (2016-2027) Figure 44. North America Aurora Kinase B Revenue Share by Country (2016-2027) Figure 45. U.S. Aurora Kinase B Revenue (2016-2027) & (US$ Million) Figure 46. Canada Aurora Kinase B Revenue (2016-2027) & (US$ Million) Figure 47. Europe Aurora Kinase B Sales Market Share by Type (2016-2027) Figure 48. Europe Aurora Kinase B Revenue Market Share by Type (2016-2027) Figure 49. Europe Aurora Kinase B Sales Market Share by Application (2016-2027) Figure 50. Europe Aurora Kinase B Revenue Market Share by Application (2016-2027) Figure 51. Europe Aurora Kinase B Sales Share by Country (2016-2027) Figure 52. Europe Aurora Kinase B Revenue Share by Country (2016-2027) Figure 53. Germany Aurora Kinase B Revenue (2016-2027) & (US$ Million) Figure 54. France Aurora Kinase B Revenue (2016-2027) & (US$ Million) Figure 55. U.K. Aurora Kinase B Revenue (2016-2027) & (US$ Million) Figure 56. Italy Aurora Kinase B Revenue (2016-2027) & (US$ Million) Figure 57. Russia Aurora Kinase B Revenue (2016-2027) & (US$ Million) Figure 58. Asia Pacific Aurora Kinase B Sales Market Share by Type (2016-2027) Figure 59. Asia Pacific Aurora Kinase B Revenue Market Share by Type (2016-2027) Figure 60. Asia Pacific Aurora Kinase B Sales Market Share by Application (2016-2027) Figure 61. Asia Pacific Aurora Kinase B Revenue Market Share by Application (2016-2027) Figure 62. Asia Pacific Aurora Kinase B Sales Share by Region (2016-2027) Figure 63. Asia Pacific Aurora Kinase B Revenue Share by Region (2016-2027) Figure 64. China Aurora Kinase B Revenue (2016-2027) & (US$ Million) Figure 65. Japan Aurora Kinase B Revenue (2016-2027) & (US$ Million) Figure 66. South Korea Aurora Kinase B Revenue (2016-2027) & (US$ Million) Figure 67. India Aurora Kinase B Revenue (2016-2027) & (US$ Million) Figure 68. Australia Aurora Kinase B Revenue (2016-2027) & (US$ Million) Figure 69. Taiwan Aurora Kinase B Revenue (2016-2027) & (US$ Million) Figure 70. Indonesia Aurora Kinase B Revenue (2016-2027) & (US$ Million) Figure 71. Thailand Aurora Kinase B Revenue (2016-2027) & (US$ Million) Figure 72. Malaysia Aurora Kinase B Revenue (2016-2027) & (US$ Million) Figure 73. Philippines Aurora Kinase B Revenue (2016-2027) & (US$ Million) Figure 74. Latin America Aurora Kinase B Sales Market Share by Type (2016-2027) Figure 75. Latin America Aurora Kinase B Revenue Market Share by Type (2016-2027) Figure 76. Latin America Aurora Kinase B Sales Market Share by Application (2016-2027) Figure 77. Latin America Aurora Kinase B Revenue Market Share by Application (2016-2027) Figure 78. Latin America Aurora Kinase B Sales Share by Country (2016-2027) Figure 79. Latin America Aurora Kinase B Revenue Share by Country (2016-2027) Figure 80. Mexico Aurora Kinase B Revenue (2016-2027) & (US$ Million) Figure 81. Brazil Aurora Kinase B Revenue (2016-2027) & (US$ Million) Figure 82. Argentina Aurora Kinase B Revenue (2016-2027) & (US$ Million) Figure 83. Middle East and Africa Aurora Kinase B Sales Market Share by Type (2016-2027) Figure 84. Middle East and Africa Aurora Kinase B Revenue Market Share by Type (2016-2027) Figure 85. Middle East and Africa Aurora Kinase B Sales Market Share by Application (2016-2027) Figure 86. Middle East and Africa Aurora Kinase B Revenue Market Share by Application (2016-2027) Figure 87. Middle East and Africa Aurora Kinase B Sales Share by Country (2016-2027) Figure 88. Middle East and Africa Aurora Kinase B Revenue Share by Country (2016-2027) Figure 89. Turkey Aurora Kinase B Revenue (2016-2027) & (US$ Million) Figure 90. Saudi Arabia Aurora Kinase B Revenue (2016-2027) & (US$ Million) Figure 91. U.A.E Aurora Kinase B Revenue (2016-2027) & (US$ Million) Figure 92. Aurora Kinase B Value Chain Figure 93. Aurora Kinase B Production Process Figure 94. Channels of Distribution Figure 95. Distributors Profiles Figure 96. Bottom-up and Top-down Approaches for This Report Figure 97. Data Triangulation Figure 98. Key Executives Interviewed

AbbVie Inc Advenchen Laboratories LLC Aeterna Zentaris Inc Amgen Inc AstraZeneca Plc Chipscreen Biosciences Ltd Cielo Therapeutics Inc Sanofi Sareum Holdings Plc